Research Topics
| Thomas V InglesbySummaryAffiliation: Johns Hopkins University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian BiodefenseT V Inglesby
The Center for Civilian Biodefense Studies, School of Medicine, Johns Hopkins University, Baltimore, MD 21202, USA
JAMA 281:1735-45. 1999..To develop consensus-based recommendations for measures to be taken by medical and public health professionals following the use of anthrax as a biological weapon against a civilian population...- Shining light on "Dark Winter"Tara O'Toole
Center for Civilian Biodefense Strategies, Johns Hopkins University, Baltimore, MD, 21202, USA
Clin Infect Dis 34:972-83. 2002..The exercise was intended to increase awareness of the scope and character of the threat posed by biological weapons among senior national security experts and to bring about actions that would improve prevention and response strategies... - Hospital preparedness for pandemic influenzaEric Toner
Center for Biosecurity of the University of Pittsburgh Medical Center, Baltimore, Maryland 21202, USA
Biosecur Bioterror 4:207-17. 2006 - Improving performance of HVAC systems to reduce exposure to aerosolized infectious agents in buildings; recommendations to reduce risks posed by biological attacksPenny J Hitchcock
Center for Biosecurity of UPMC, Baltimore, MD 21202, USA
Biosecur Bioterror 4:41-54. 2006.... - Regional approaches to hospital preparednessBeth Maldin
The Center for Biosecurity of The University of Pittsburgh Medical Center, Baltimore, Maryland, USA
Biosecur Bioterror 5:43-53. 2007..It aims to identify key ingredients for building successful regional partnerships for healthcare preparedness as well as critical challenges and policy and practical recommendations for their development and sustainability... 
Healthcare coalitions: the new foundation for national healthcare preparedness and response for catastrophic health emergenciesBrooke Courtney
Center for Biosecurity of the University of Pittsburgh Medical Center, Baltimore, Maryland 21202, USA
Biosecur Bioterror 7:153-63. 2009....- Public health and medical responses to the 1957-58 influenza pandemicD A Henderson
Center for Biosecurity of the University of Pittsburgh Medical Center UPMC, Baltimore, Maryland 21202, USA
Biosecur Bioterror 7:265-73. 2009..While it cannot be predicted with absolute certainty how the H1N1 pandemic might play out in the U.S. this fall, lessons from the 1957-58 influenza pandemic provide useful and practical insights for current planning and response efforts... - Anthrax as a biological weapon, 2002: updated recommendations for managementThomas V Inglesby
Johns Hopkins Center for Civilian Biodefense Strategies, Johns Hopkins University, Baltimore, MD 21202, USA
JAMA 287:2236-52. 2002..To review and update consensus-based recommendations for medical and public health professionals following a Bacillus anthracis attack against a civilian population... - Roundtable discussion: corporate pandemic preparednessBeth Maldin-Morgenthau
Center for Biosecurity of UPMC, 621 E. Pratt St, Suite 210, Baltimore, MD 21202, USA
Biosecur Bioterror 5:168-73. 2007 - Management of anthraxJohn G Bartlett
Johns Hopkins University Center for Civilian Biodefense Strategies, Johns Hopkins University School of Medicine, Baltimore, MD 21287 0003, USA
Clin Infect Dis 35:851-8. 2002..This article provides clinicians with clinically relevant information about the diagnosis and management of anthrax... - Biosurveillance where it happens: state and local capabilities and needsEric S Toner
Center for Biosecurity of UPMC, Baltimore, Maryland 21202, USA
Biosecur Bioterror 9:321-30. 2011..We also sought to identify those policies or actions that would improve state and local biosurveillance and make recommendations to federal policymakers who are interested in improving national biosurveillance capabilities... - After Fukushima: managing the consequences of a radiological releaseJoe Fitzgerald
Center for Biosecurity of UPMC, 621 East Pratt St, Ste, 210, Baltimore, MD 21202, USA
Biosecur Bioterror 10:228-36. 2012..S.; and makes recommendations for steps that can be taken to strengthen U.S. government, industry, and community response to large-scale accidents at nuclear power plants... - Smallpox vaccination in 2003: key information for cliniciansJohn Bartlett
Center for Civilian Biodefense Strategies and School of Medicine, Johns Hopkins University, Baltimore, MD 21287-0003, USA
Clin Infect Dis 36:883-902. 2003 - Systemic collapse: Medical care in the aftermath of Hurricane KatrinaCrystal Franco
Center for Biosecurity of the University of Pittsburgh Medical Center, Baltimore, Maryland 21202, USA
Biosecur Bioterror 4:135-46. 2006..The article makes recommendations for improvement... - Bulls, Bears, and Birds: Preparing the Financial Industry for an Avian Influenza PandemicBeth Maldin
Center for Biosecurity of the University of Pittsburgh Medical Center, Baltimore, Maryland 21202, USA
Biosecur Bioterror 3:363-7. 2005.... - Navigating the storm: report and recommendations from the Atlantic Storm exerciseBradley T Smith
Center for Biosecurity of the University of Pittsburgh Medical Center, Baltimore, Maryland 21202, USA
Biosecur Bioterror 3:256-67. 2005..Medical, public health, and diplomatic response systems and critical medical resources (e.g., medicines and vaccines) must be in place before a bioattack occurs or a pandemic emerges... - The national disaster medical system: past, present, and suggestions for the futureCrystal Franco
Center for Biosecurity of the University of Pittsburgh Medical Center, Baltimore, Maryland 21202, USA
Biosecur Bioterror 5:319-25. 2007.... - High-containment biodefense research laboratories: meeting report and center recommendationsGigi Kwik Gronvall
The Center for Biosecurity of The University of Pittsburgh Medical Center, Baltimore, Maryland 21202, USA
Biosecur Bioterror 5:75-85. 2007 - Challenges to global surveillance and response to infectious disease outbreaks of international importancePenny Hitchcock
Center for Biosecurity, University of Pittsburgh Medical Center, Baltimore, Maryland 21202, USA
Biosecur Bioterror 5:206-27. 2007..An assessment of the potential contribution of appropriate diagnostic tests to surveillance and response is included... - The prospect of using alternative medical care facilities in an influenza pandemicClarence Lam
University of Maryland School of Medicine, Baltimore, University of Pittsburgh Medical Center, Baltimore, MD 21202, USA
Biosecur Bioterror 4:384-90. 2006.... - Disease mitigation measures in the control of pandemic influenzaThomas V Inglesby
Center for Biosecurity of the University of Pittsburgh Medical Center, Baltimore, Maryland 21202, USA
Biosecur Bioterror 4:366-75. 2006..Finally, the article summarizes the authors' judgments of the likely effectiveness and likely adverse consequences of the range of disease mitigation measures and suggests priorities and practical actions to be taken... - Comments from the Center for Biosecurity of UPMC on proposed revisions to federal quarantine rulesJennifer B Nuzzo
Center for Biosecurity of the University of Pittsburgh Medical Center, Baltimore, Maryland, USA
Biosecur Bioterror 4:204-6. 2006..The Center for Biosecurity of UPMC reviewed the proposed revisions to the quarantine regulations and submitted to CDC the following analysis as its official comments on the revised rules... - The Globalization of US Medical Countermeasure Production and Its Implications for National SecurityAmesh A Adalja
Amesh A Adalja, MD, is an Associate Samuel B Wollner is an Analyst and Thomas V Inglesby, MD, is Director and Chief Executive Officer all at the Center for Biosecurity of UPMC, Baltimore, Maryland George Poste, PhD, is Chief Scientist, Complex Adaptive Systems Initiative, and Regents Professor and Del E Webb Chair in Health Innovation, Arizona State University, Tempe
Biosecur Bioterror 10:255-7. 2012..Readers may submit ideas to the column's editor, Amesh A. Adalja, MD, through the Journal's editorial office at jfox@upmc-biosecurity.org ... - Executive government positions of influence in biodefense: the Bio-Plum bookAri Schuler
Center for Biosecurity of the University of Pittsburgh Medical Center, Baltimore, Maryland 21202, USA
Biosecur Bioterror 2:328-41. 2004 - Biodefense R&D: anticipating future threats, establishing a strategic environmentBradley T Smith
Johns Hopkins Center for Civilian Biodefense Strategies, Baltimore, Maryland, USA
Biosecur Bioterror 1:193-202. 2003 - Engineered H5N1: a rare time for restraint in scienceThomas V Inglesby
Center for Biosecurity of UPMC, Baltimore, Maryland, USA
Ann Intern Med 156:460-2. 2012..If a highly compelling case is made for continued work on this strain despite the risks, the work should be controlled and should merit the greatest scrutiny... - Biosecurity: responsible stewardship of bioscience in an age of catastrophic terrorismGigi Kwik
Johns Hopkins Center for Civilian Biodefense Strategies, Baltimore, Maryland, USA
Biosecur Bioterror 1:27-35. 2003 - Anthrax 2001: observations on the medical and public health responseElin Gursky
ANSER Institute for Homeland Security, Arlington, Virginia, USA
Biosecur Bioterror 1:97-110. 2003 - Flexible defenses roundtable meeting: promoting the strategic innovation of medical countermeasuresGigi Kwik Gronvall
Biosecur Bioterror 5:271-7. 2007 - Taking the measure of countermeasures: leaders' views on the nation's capacity to develop biodefense countermeasuresLynne Gilfillan
Government Operations, Sarnoff Corporation, Arlington, VA 22209, USA
Biosecur Bioterror 2:320-7. 2004 - Augmentation of hospital critical care capacity after bioterrorist attacks or epidemics: recommendations of the Working Group on Emergency Mass Critical CareLewis Rubinson
Crit Care Med 33:2393-403. 2005..S. hospitals facing these situations have not been developed. The Working Group offers recommendations for this situation... - Toward biosecurityThomas V Inglesby
Biosecur Bioterror 1:1-3. 2003